BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38463223)

  • 1. Immunotherapy and radiotherapy for older patients with locally advanced rectal cancer unfit for surgery or decline surgery: a practical proposal by the International Geriatric Radiotherapy Group.
    Nguyen NP; Mohammadianpanah M; SunMyint A; Page BR; Vinh-Hung V; Gorobets O; Arenas M; Mazibuko T; Giap H; Vasileiou M; Dutheil F; Tuscano C; Karlsson UL; Dahbi Z; Natoli E; Li E; Kim L; Oboite J; Oboite E; Bose S; Vuong T
    Front Oncol; 2024; 14():1325610. PubMed ID: 38463223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy and Modern Radiotherapy Technique for Older Patients with Locally Advanced Head and Neck Cancer: A Proposed Paradigm by the International Geriatric Radiotherapy Group.
    Nguyen NP; Kim L; Thariat J; Baumert BG; Mazibuko T; Gorobets O; Vinh-Hung V; Giap H; Mehmood T; Vincent F; Chi A; Basu T; Loganadane G; Mohammadianpanah M; Karlsson U; Oboite E; Oboite J; Ali A; Page BR
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
    Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
    [No Abstract]   [Full Text] [Related]  

  • 4. Short-course radiotherapy combined with CAPOX and Toripalimab for the total neoadjuvant therapy of locally advanced rectal cancer: a randomized, prospective, multicentre, double-arm, phase II trial (TORCH).
    Wang Y; Shen L; Wan J; Zhang H; Wu R; Wang J; Wang Y; Xu Y; Cai S; Zhang Z; Xia F
    BMC Cancer; 2022 Mar; 22(1):274. PubMed ID: 35291966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy and Hypofractionated Radiotherapy in Older Patients with Locally Advanced Cutaneous Squamous-Cell Carcinoma of the Head and Neck: A Proposed Paradigm by the International Geriatric Radiotherapy Group.
    Nguyen NP; Thariat J; Gorobets O; Vinh-Hung V; Kim L; Blanco SC; Vasileiou M; Arenas M; Mazibuko T; Giap H; Vincent F; Chi A; Loganadane G; Mohammadianpanah M; Rembielak A; Karlsson U; Ali A; Bose S; Page BR
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is immunotherapy at reduced dose and radiotherapy for older patients with locally advanced non-small lung cancer feasible?-a narrative review by the international geriatric radiotherapy group.
    Vinh-Hung V; Gorobets O; Duerinkcx A; Dutta S; Oboite E; Oboite J; Ali A; Mazibuko T; Karlsson U; Chi A; Lehrman D; Mohammed OH; Mohammadianpanah M; Loganadane G; Migliore N; Vasileiou M; Nguyen NP; Giap H
    Transl Cancer Res; 2022 Sep; 11(9):3298-3308. PubMed ID: 36237270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short course radiotherapy and delayed surgery for locally advanced rectal cancer in frail patients: is it a valid option?
    Lancellotti F; Solinas L; Sagnotta A; Mancini S; Cosentino LPM; Belardi A; Battaglia B; Mirri MA; Ciabattoni A; Salerno F; Loponte M
    Eur J Surg Oncol; 2021 Aug; 47(8):2046-2052. PubMed ID: 33757649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 9. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 10. [Short-course radiotherapy combined with CAPOX and PD-1 inhibitor for the total neoadjuvant therapy of locally advanced rectal cancer: the preliminary single-center findings of a prospective, multicentre, randomized phase II trial (TORCH)].
    Wang YQ; Shen LJ; Wan JF; Zhang H; Wang Y; Wu X; Wang JW; Wang RJ; Sun YQ; Tong T; Huang D; Wang L; Sheng WQ; Zhang X; Cai GX; Xu Y; Cai SJ; Zhang Z; Xia F
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):448-458. PubMed ID: 37217353
    [No Abstract]   [Full Text] [Related]  

  • 11. Stereotactic Body Radiotherapy and Immunotherapy for Older Patients with Oligometastases: A Proposed Paradigm by the International Geriatric Radiotherapy Group.
    Nguyen NP; Ali A; Vinh-Hung V; Gorobets O; Chi A; Mazibuko T; Migliore N; Vasileiou M; Lehrman D; Mohammadianpanah M; Javadinia SA; Loganadane G; Basu T; Bose S; Karlsson U; Giap H
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TORCH-R trial protocol: hypofractionated radiotherapy combined with chemotherapy and toripalimab for locally recurrent rectal cancer: a prospective, single-arm, two-cohort, phase II trial.
    Wan J; Wu R; Fu M; Shen L; Zhang H; Wang Y; Wang Y; Zhou S; Chen Y; Xia F; Zhang Z
    Front Oncol; 2023; 13():1304767. PubMed ID: 38053659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study.
    Chen G; Jin Y; Guan WL; Zhang RX; Xiao WW; Cai PQ; Liu M; Lin JZ; Wang FL; Li C; Quan TT; Xi SY; Zhang HZ; Pan ZZ; Wang F; Xu RH
    Lancet Gastroenterol Hepatol; 2023 May; 8(5):422-431. PubMed ID: 36870360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of radiotherapy in the treatment of rectal cancer in older patients.
    Myint AS; Gérard JP
    Eur J Surg Oncol; 2020 Mar; 46(3):349-357. PubMed ID: 31926607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-course radiation followed by mFOLFOX-6 plus avelumab for locally-advanced rectal adenocarcinoma.
    Shamseddine A; Zeidan YH; Kreidieh M; Khalifeh I; Turfa R; Kattan J; Mukherji D; Temraz S; Alqasem K; Amarin R; Al Awabdeh T; Deeba S; Jamali F; Mohamad I; Elkhaldi M; Daoud F; Al Masri M; Dabous A; Hushki A; Jaber O; Khoury C; El Husseini Z; Charafeddine M; Al Darazi M; Geara F
    BMC Cancer; 2020 Sep; 20(1):831. PubMed ID: 32873251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons].
    Sun TT; Wang L; Yao YF; Peng YF; Zhao J; Zhan TC; Leng JH; Wang HY; Chen N; Chen PJ; Li YJ; Zhang X; Liu XZ; Zhang Y; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):550-559. PubMed ID: 31238634
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
    Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
    Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy in the preoperative neoadjuvant treatment of locally advanced rectal cancer.
    Yu Z; Hao Y; Huang Y; Ling L; Hu X; Qiao S
    Front Oncol; 2023; 13():1300535. PubMed ID: 38074690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-course radiotherapy combined with chemotherapy and PD-1 inhibitor in low-lying early rectal cancer: study protocol for a single-arm, multicentre, prospective, phase II trial (TORCH-E).
    Chen Y; Wang Y; Zhang H; Wan J; Shen L; Wang Y; Zhou M; Wu R; Yang W; Zhou S; Cai S; Li X; Zhang Z; Xia F
    BMJ Open; 2023 Oct; 13(10):e076048. PubMed ID: 37802608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.